Stock Price
5.95
Daily Change
-0.01 -0.17%
Monthly
5.50%
Yearly
13.12%
Q2 Forecast
5.82

Ardelyx reported $6.02M in EBITDA for its fiscal quarter ending in December of 2025.





Ebitda Change Date
Abbott USD 3.27B 178M Dec/2025
Amgen USD 5.14B 775M Dec/2025
Ardelyx USD 6.02M 447K Dec/2025
aTyr Pharma USD 25.85M 52.43M Dec/2025
Corcept Therapeutics USD 4.2M 6.5M Dec/2025
Curis USD -12.3M 231K Sep/2023
Sanofi EUR 5.66B 3.77B Sep/2025
TG Therapeutics USD 32.69M 5M Sep/2025
United Therapeutics USD 379.5M 83.4M Dec/2025
Xoma USD 2.52M 7.98M Jun/2024